A potential association between immunosenescence and high COVID-19 related mortality among elderly patients with cardiovascular diseases
Abstract Elderly patients with cardiovascular diseases account for a large proportion of Corona virus Disease 2019(COVID-19)related deaths. COVID-19, as a new coronavirus, mainly targets the patient’s lung triggering a cascade of innate and adaptive immune responses in the host. The principal causes...
Main Authors: | Yuanyuan Wang, Shu-Chao Pang, Ying Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Immunity & Ageing |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12979-021-00234-z |
Similar Items
-
T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
by: Kohsuke Shirakawa, et al.
Published: (2021-09-01) -
COVID‐19 and cardiovascular problems in elderly patients: Food for thought
by: Raffaele Costa, et al.
Published: (2021-06-01) -
COVID-19 and cardiovascular disease in elderly patients: a challenge in the challenge
by: Raffaele Costa, et al.
Published: (2020-06-01) -
Immunosenescence in neurocritical care
by: Shigeaki Inoue, et al.
Published: (2018-10-01) -
Immunosenescence and novel vaccination strategies for the elderly
by: Michael Geoffrey Dorrington, et al.
Published: (2013-06-01)